2009Journal of Clinical CardiologyRequires access

Long prognostic value of B-natriuretic peptide on admission in patients with chronic heart failure

Wenyong Zhang

Open publisher page 0 citations

Abstract

Objective:To evaluate the long prognostic value of plasma B-natriuretic peptide(BNP) on predicting cardiovascular events after hospital discharge in patients with chronic heart failure(CHF).Method:Patients with CHF(n=134) were included in this study.Plasma BNP level was obtained by a rapid immunofluorescence assay in all patients.Left ventricular end diastolic diameter(LVEDD) and cardiothoracic ratio(CRT) were performed within 24 h before or after catheterization.All CHF patients were received conventional therapy and the rates of cardiac death and rehospitalization were used as end points during 3-year follow up.Result:①LVEDD,CRT and BNP were increased in patients with cardiac events compared with patients without cardiac events(P0.01).②Multivariant logistic analysis showed that the independent factors for cardiac events in patients with CHF was BNP(OR=1.005,95%CI 1.002-1.007).③The areas under the receiver operating curve(ROC),when BNP was used to predict cardiac death of CHF,was 0.846(95%CI 0.771-0.922).For predicting cardiac death in patients with CHF,BNP cutoff point of 720.5 ng/L had a sensitivity of 76.5%,a specificity of 75.2%.④The survival rate of patients in group of BNP≤702.5 ng/L was much higher than that in group of BNP702.5 ng/L(OR=4.383,95%CI 1.407-13.650).Kaplan-Meier cumulative survival analysis supported the above results.Conclusion:Plasma BNP is an independent predictor for prognosis of patients with CHF.

About this research paper

What this paper is about

Objective:To evaluate the long prognostic value of plasma B-natriuretic peptide(BNP) on predicting cardiovascular events after hospital discharge in patients with chronic heart failure(CHF).Method:Patients with CHF(n=134) were included in this study.Plasma BNP level was obtained by a rapid immunofluorescence assay in all patients.Left ventricular end diastolic diameter(LVEDD) and cardiothoracic ratio(CRT) were performed within 24 h before or after catheterization.All CHF patients were received conventional therapy and the rates of cardiac death and rehospitalization were used as end points during 3-year follow up.Result:①LVEDD,CRT and BNP were increased in patients with cardiac events compared with patients without cardiac events(P0.01).②Multivariant logistic analysis showed that the independent factors for cardiac events in patients with CHF was BNP(OR=1.005,95%CI 1.002-1.007).③The areas under the receiver operating curve(ROC),when BNP was used to predict cardiac death of CHF,was 0.846(95%CI 0.771-0.922).For predicting cardiac death in patients with CHF,BNP cutoff point of 720.5 ng/L had a sensitivity of 76.5%,a specificity of 75.2%.④The survival rate of patients in group of BNP≤702.5 ng/L was much higher than that in group of BNP702.5 ng/L(OR=4.383,95%CI 1.407-13.650).Kaplan-Meier cumulative survival analysis supported the above results.Conclusion:Plasma BNP is an independent predictor for prognosis of patients with CHF.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the long prognostic value of plasma B-natriuretic peptide(BNP) on predicting cardiovascular events after hospital discharge in patients with chronic heart failure(CHF).Method:Patients with CHF(n=134) were included in this study.Plasma BNP level was obtained by a rapid immunofluorescence assay in all patients.Left ventricular end diastolic diameter(LVEDD) and cardiothoracic ratio(CRT) were performed within 24 h before or after catheterization.All CHF patients were received conventional therapy and the rates of cardiac death and rehospitalization were used as end points during 3-year follow up.Result:①LVEDD,CRT and BNP were increased in patients with cardiac events compared with patients without cardiac events(P0.01).②Multivariant logistic analysis showed that the independent factors for cardiac events in patients with CHF was BNP(OR=1.005,95%CI 1.002-1.007).③The areas under the receiver operating curve(ROC),when BNP was used to predict cardiac death of CHF,was 0.846(95%CI 0.771-0.922).For predicting cardiac death in patients with CHF,BNP cutoff point of 720.5 ng/L had a sensitivity of 76.5%,a specificity of 75.2%.④The survival rate of patients in group of BNP≤702.5 ng/L was much higher than that in group of BNP702.5 ng/L(OR=4.383,95%CI 1.407-13.650).Kaplan-Meier cumulative survival analysis supported the above results.Conclusion:Plasma BNP is an independent predictor for prognosis of patients with CHF.

Key concepts: Medicine, Internal medicine, Cardiology, Heart failure, Natriuretic peptide, Receiver operating characteristic, Brain natriuretic peptide, Cardiac catheterization

Related papers

Back to paper searchBrowse research topicsOriginal source
Long prognostic value of B-natriuretic peptide on admission in patients with chronic heart failure — Research Paper | ScholarLens